MIR4679-1: A Drug Target / Disease Biomarker (G100616128)
MIR4679-1: A Drug Target / Disease Biomarker
MIR4679-1 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the Mir gene family, which encodes for a family of cytoskeletal proteins that play a role in the regulation of cell shape and movement.
One of the unique aspects of MIR4679-1 is its ability to interact with multiple intracellular signaling pathways. This protein has been shown to play a role in the regulation of cell adhesion, migration, and invasion, as well as in the regulation of inflammation and metabolism.
MIR4679-1 has also been shown to be involved in the regulation of insulin sensitivity and glucose metabolism. This protein has been shown to interact with multiple intracellular signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth, differentiation, and inflammation.
In addition to its role in intracellular signaling, MIR4679-1 has also been shown to have important functions in the regulation of cellular interactions and the development of tissues. This protein has been shown to play a role in the regulation of cell-cell adhesion, as well as in the regulation of cell migration and the formation of tissues.
MIR4679-1 has also been shown to have important functions in the regulation of inflammation and infection. This protein has been shown to play a role in the regulation of immune cell function and the regulation of inflammation.
Despite its importance in multiple cellular processes, MIR4679-1 has not yet been identified as a drug target or biomarker. Further research is needed to fully understand the role of this protein in cellular processes and its potential as a drug target or biomarker.
Protein Name: MicroRNA 4679-1
The "MIR4679-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4679-1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783
